42 employees
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
2007
$30M
from 1 investors over 1 rounds
Regulus Therapeutics raised $30M on June 20, 2016
Investors: Oxford Finance LLC